As part of its postmarketing requirements, Horizon must also complete the ongoing OPTIC-X trial, which is expected later this year. • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
